EvolveImmune Therapeutics

EvolveImmune is pioneering a pipeline of unique trispecific T cell engagers with integrated CD2 costimulation

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

EvolveImmune is pioneering a pipeline of unique trispecific T cell engagers with integrated CD2 costimulation. The EVOLVE platform tackles the treatment challenges of cancer cell resistance to current immunotherapies.

02Backed By1 investor

PVPfizer Ventures→

03Similar Companies

A

Is this your company? Claim your profile

Amphivena

Biotech & Life Sciences

→

CT

Clasp Therapeutics

Biotech & Life Sciences

→

TT

TwoStep Therapeutics

Biotech & Life Sciences

→

M

Micromet

Biotech & Life Sciences

→

A

Adaptimmune

Biotech & Life Sciences

→

04Startup DNA

11

signals

Sectors
Business Model
Technology